These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 955235)

  • 1. Systemic effects and percutaneous absorption of topically applied 0.1% hydrocortisone 17-butyrate.
    Kukita A; Yamada K; Takeda Y
    Dermatologica; 1976; 152 Suppl 1():197-207. PubMed ID: 955235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic effects of topical corticosteroid treatment].
    Yamada K
    Nihon Hifuka Gakkai Zasshi; 1972 Nov; 82(11):1079-92. PubMed ID: 4542238
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenal suppression with topical hydrocortisone butyrate.
    Hendrikse JC; Moolenaar AJ
    Dermatologica; 1973; 147(3):191-7. PubMed ID: 4780208
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(4):249-57. PubMed ID: 786608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
    Wendt H; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy.
    Munro DD; Wilson L
    Br Med J; 1975 Sep; 3(5984):626-8. PubMed ID: 1164639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
    Allenby CF; Sparkes CG
    Br J Dermatol; 1981 Feb; 104(2):179-83. PubMed ID: 7011356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of 17 ketosteroids and 17 hydroxycorticosteroids after inunction of hydrocortisone ointment; attempts to demonstrate systemic absorption from topically applied hydrocortisone ointment.
    SMITH CC
    J Invest Dermatol; 1955 Jul; 25(1):67-9. PubMed ID: 13242906
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous absorption of corticosteroids. Adrenocortical suppression with total body inunction.
    Carr RD; Tarnowski WM
    Acta Derm Venereol; 1968; 48(5):417-28. PubMed ID: 4177565
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical and systemic effects of hydrocortisone 17-butyrate.
    Wieriks J; Hespe W; Jaitly KD; van Kan BL
    Dermatologica; 1976; 152 Suppl 1():181-95. PubMed ID: 955234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experiences with hydrocortisone 17-butyrate.
    Yasuda T
    Dermatologica; 1976; 152 Suppl 1():221-9. PubMed ID: 782956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of various corticosteroids through epidermis in vitro.
    Ponec M; Polano MK
    Arch Dermatol Res; 1979 May; 265(1):101-4. PubMed ID: 475440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrocortisone 17-butyrate (Locoid) 0.1% fatty cream versus desonide (Apolar) 0.1% ointment in the treatment of patients suffering from atopic dermatitis.
    Rajka G; Verjans HL
    J Int Med Res; 1986; 14(2):85-90. PubMed ID: 3516754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hydrocortisone, applied locally to the skin, on the eosinophil count and the plasma level of 17-hydroxycorticosteroids.
    GEMZELL CA; HARD S; NILZEN A
    Acta Derm Venereol; 1955; 35(4-5):327-33. PubMed ID: 13301310
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo.
    Haapasaari KM; Risteli J; Koivukangas V; Oikarinen A
    Acta Derm Venereol; 1995 Jul; 75(4):269-71. PubMed ID: 8578945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydrocortisone 17-butyrate on the percutaneous absorption of antibiotics.
    Simon N; Dobozy A
    Dermatologica; 1976; 152 Suppl 1():215-9. PubMed ID: 955236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous absorption of hydrocortisone increases with long-term administration. In vivo studies in the rhesus monkey.
    Wester RC; Noonan PK; Maibach HI
    Arch Dermatol; 1980 Feb; 116(2):186-8. PubMed ID: 6766708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous and systemic disposition of hexamethylene lauramide and its penetration enhancement effect on hydrocortisone in a rat sandwich skin-flap model.
    Tang-Liu DD; Neff J; Zolezio H; Sandri R
    Pharm Res; 1988 Aug; 5(8):477-81. PubMed ID: 3244654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.